Rahman S, McBride W J
Department of Psychiatry, Institute of Psychiatric Research, Indiana University School of Medicine, Indianapolis 46202-4887, USA.
J Neurochem. 2001 Jun;77(5):1248-55. doi: 10.1046/j.1471-4159.2001.00326.x.
The objective of the present study was to examine the effects of perfusion of dopamine (DA) D1- and D2-like receptor agonists in the nucleus accumbens (ACB) on the long-loop negative feedback regulation of mesolimbic somatodendritic DA release in the ventral tegmental area (VTA) of Wistar rats employing ipsilateral dual probe in vivo microdialysis. Perfusion of the ACB for 60 min with the D1-like receptor agonist SKF 38393 (SKF, 1-100 microM) dose-dependently reduced the extracellular levels of DA in the ACB, whereas the extracellular levels of DA in the VTA were not changed. Similarly, application of the D2-like receptor agonist quinpirole (Quin, 1-100 microM) through the microdialysis probe in the ACB reduced the extracellular levels of DA in the ACB in a concentration-dependent manner, whereas extracellular levels of DA in the VTA were not altered. Co-application of SKF (100 microM) and Quin (100 microM) produced concomitant reductions in the extracellular levels of DA in the ACB and VTA. The reduction in extracellular levels of DA in the ACB and VTA produced by co-infusion of SKF and Quin was reversed in the presence of either 100 microM SCH 23390 (D1-like antagonist) or 100 microM sulpiride (D2-like antagonist). Overall, the results suggest that (a) activation of dopamine D1- or D2-like receptors can independently regulate local terminal DA release in the ACB, whereas stimulation of both subtypes is required for activation of the negative feedback pathway to the VTA.
本研究的目的是采用同侧双探针体内微透析技术,研究向伏隔核(ACB)灌注多巴胺(DA)D1样和D2样受体激动剂对Wistar大鼠腹侧被盖区(VTA)中脑边缘树突体DA释放的长环负反馈调节的影响。用D1样受体激动剂SKF 38393(SKF,1 - 100 μM)向ACB灌注60分钟,可剂量依赖性地降低ACB中DA的细胞外水平,而VTA中DA的细胞外水平未发生变化。同样,通过ACB中的微透析探针应用D2样受体激动剂喹吡罗(Quin,1 - 100 μM)也以浓度依赖性方式降低了ACB中DA的细胞外水平,而VTA中DA的细胞外水平未改变。同时应用SKF(100 μM)和Quin(100 μM)可使ACB和VTA中DA的细胞外水平同时降低。在存在100 μM SCH 23390(D1样拮抗剂)或100 μM舒必利(D2样拮抗剂)的情况下,SKF和Quin共同输注所导致的ACB和VTA中DA细胞外水平的降低被逆转。总体而言,结果表明:(a)多巴胺D1样或D2样受体的激活可独立调节ACB中局部终末DA的释放,而激活向VTA的负反馈途径则需要两种亚型的刺激。